119 related articles for article (PubMed ID: 23706899)
1. Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder.
Hopkins SC; Reasner DS; Koblan KS
Psychiatry Res; 2013 Aug; 208(3):285-7. PubMed ID: 23706899
[TBL] [Abstract][Full Text] [Related]
2. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
[TBL] [Abstract][Full Text] [Related]
4. Association of the COMT val158met variant with antidepressant treatment response in major depression.
Baune BT; Hohoff C; Berger K; Neumann A; Mortensen S; Roehrs T; Deckert J; Arolt V; Domschke K
Neuropsychopharmacology; 2008 Mar; 33(4):924-32. PubMed ID: 17522626
[TBL] [Abstract][Full Text] [Related]
5. Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.
Narasimhan S; Aquino TD; Multani PK; Rickels K; Lohoff FW
Psychiatry Res; 2012 Jun; 198(1):112-5. PubMed ID: 22417933
[TBL] [Abstract][Full Text] [Related]
6. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
Szegedi A; Rujescu D; Tadic A; Müller MJ; Kohnen R; Stassen HH; Dahmen N
Pharmacogenomics J; 2005; 5(1):49-53. PubMed ID: 15520843
[TBL] [Abstract][Full Text] [Related]
7. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
8. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
[TBL] [Abstract][Full Text] [Related]
9. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome.
Fernández-de-Las-Peñas C; Ambite-Quesada S; Gil-Crujera A; Cigarán-Méndez M; Peñacoba-Puente C
J Pain; 2012 Nov; 13(11):1068-74. PubMed ID: 23025981
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
[TBL] [Abstract][Full Text] [Related]
12. Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression.
Chiesa A; Lia L; Alberti S; Lee SJ; Han C; Patkar AA; Pae CU; Serretti A
Int J Psychiatry Clin Pract; 2014 Jun; 18(2):97-102. PubMed ID: 24555772
[TBL] [Abstract][Full Text] [Related]
13. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
Lee HY; Kim YK
Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
[TBL] [Abstract][Full Text] [Related]
15. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
Corvol JC; Bonnet C; Charbonnier-Beaupel F; Bonnet AM; Fiévet MH; Bellanger A; Roze E; Meliksetyan G; Ben Djebara M; Hartmann A; Lacomblez L; Vrignaud C; Zahr N; Agid Y; Costentin J; Hulot JS; Vidailhet M
Ann Neurol; 2011 Jan; 69(1):111-8. PubMed ID: 21280081
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis.
Watanabe K; Kakeda S; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umene-Nakano W; Watanabe R; Nakamura J; Korogi Y
Psychiatry Res; 2015 Sep; 233(3):481-7. PubMed ID: 26253436
[TBL] [Abstract][Full Text] [Related]
17. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
Arias B; Serretti A; Lorenzi C; Gastó C; Catalán R; Fañanás L
J Affect Disord; 2006 Feb; 90(2-3):251-6. PubMed ID: 16356553
[TBL] [Abstract][Full Text] [Related]
18. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
Rakvåg TT; Klepstad P; Baar C; Kvam TM; Dale O; Kaasa S; Krokan HE; Skorpen F
Pain; 2005 Jul; 116(1-2):73-8. PubMed ID: 15927391
[TBL] [Abstract][Full Text] [Related]
19. The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching.
Colzato LS; Waszak F; Nieuwenhuis S; Posthuma D; Hommel B
Neuropsychologia; 2010 Jul; 48(9):2764-8. PubMed ID: 20434465
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder.
Illi A; Setälä-Soikkeli E; Kampman O; Viikki M; Nuolivirta T; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Psychiatry Res; 2010 Mar; 176(1):85-7. PubMed ID: 20071037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
